Snowball logo
logo
NOV

Novo Nordisk A/S

€39.945-€0.06Β  (0.15%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
140,800176,9541,733,818.42,176,632.4308,385.9328,752.9
COGS
23,65828,448266,984.2333,701.958,65963,621
Gross Profit
117,142148,5061,466,834.21,842,930.6249,726.9265,131.9
Operating Expenses & Income
Operating Income
58,64474,809765,710.5961,928.2127,677.3142,201
Total Operating Expenses
58,49873,697701,123.7881,002.4122,049.6123,015.6
R&D Expenses
17,77224,047242,185.6360,234.951,924.858,079.9
Selling General & Admin Expenses
4,0504,46736,242.439,544.75,9695,325
Earnings from Continuing Operations
Interest Expense
(289)(378)(5,516.6)(12,292.1)(6,763.1)(1,621.1)
Interest Income
5582397,98013,776.21,26916,979
Income Tax Expense
11,32313,537156,696.9196,397.128,044.332,290
Net Income
Net Income
47,75755,525624,690756,926.6102,209.3116,384
Supplemental
EBIT
59,51575,569785,432.9965,615.8137,016.7150,083.7
EBITDA
64,82680,875855,700.51,029,662.4158,950.5177,194.5
In millions of EUR, except % and values per 1 share